Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1131

1.

[Invasive yeast infections in neutropenic patients].

Ruiz Camps I, Jarque I.

Rev Iberoam Micol. 2016 Jul 6. pii: S1130-1406(16)00015-2. doi: 10.1016/j.riam.2015.11.001. [Epub ahead of print] Spanish.

PMID:
27395023
2.

[Fungal colonization in preterm neonates weighing less than 1500g admitted to the neonatal intensive care unit].

Benjamin MD, Jolivet E, Desbois N, Pignol J, Ketterer-Martinon S, Pierre-Louis L, Flechelles O.

Arch Pediatr. 2016 Jun 27. pii: S0929-693X(16)30258-5. doi: 10.1016/j.arcped.2016.05.018. [Epub ahead of print] French.

PMID:
27364939
3.

The evaluation of local oxidative/nitrosative stress in patients with pityriasis versicolor: a preliminary study.

Kurutas EB, Ozturk P.

Mycoses. 2016 Jun 22. doi: 10.1111/myc.12522. [Epub ahead of print]

PMID:
27329971
4.

Exploration of anti-Malassezia potential of Nyctanthes arbor-tristis L. and their application to combat the infection caused by Mala s1 a novel allergen.

Mishra RK, Mishra V, Pandey A, Tiwari AK, Pandey H, Sharma S, Pandey AC, Dikshit A.

BMC Complement Altern Med. 2016 Mar 31;16:114. doi: 10.1186/s12906-016-1092-2.

5.

Size- and shape-dependent clinical and mycological efficacy of silver nanoparticles on dandruff.

Anwar MF, Yadav D, Jain S, Kapoor S, Rastogi S, Arora I, Samim M.

Int J Nanomedicine. 2016 Jan 6;11:147-61. doi: 10.2147/IJN.S86828. eCollection 2016.

6.

Comprehensive analysis of the skin fungal microbiota of astronauts during a half-year stay at the International Space Station.

Sugita T, Yamazaki T, Makimura K, Cho O, Yamada S, Ohshima H, Mukai C.

Med Mycol. 2016 Mar;54(3):232-9. doi: 10.1093/mmy/myv121. Epub 2016 Jan 14.

PMID:
26773135
7.

Clinical evaluation of an antiinflammatory and antioxidant diet effect in 30 dogs affected by chronic otitis externa: preliminary results.

Di Cerbo A, Centenaro S, Beribè F, Laus F, Cerquetella M, Spaterna A, Guidetti G, Canello S, Terrazzano G.

Vet Res Commun. 2016 Mar;40(1):29-38. doi: 10.1007/s11259-015-9651-4. Epub 2016 Jan 7.

8.

Malassezia species in healthy skin and in dermatological conditions.

Prohic A, Jovovic Sadikovic T, Krupalija-Fazlic M, Kuskunovic-Vlahovljak S.

Int J Dermatol. 2016 May;55(5):494-504. doi: 10.1111/ijd.13116. Epub 2015 Dec 29. Review.

PMID:
26710919
9.

[2011 Epidemiological Survey of Dermatomycoses in Japan].

Sei Y.

Med Mycol J. 2015;56(4):J129-35. doi: 10.3314/mmj.56.J129. Japanese.

10.

Comparison of lipid profiles of Malassezia pachydermatis strains isolated from dogs with otitis externa and without clinical symptoms of disease.

Czyzewska U, Siemieniuk M, Pyrkowska A, Nowakiewicz A, Bieganska M, Dabrowska I, Bartoszewicz M, Dobrzyn P, Tylicki A.

Mycoses. 2016 Jan;59(1):20-7. doi: 10.1111/myc.12429. Epub 2015 Nov 11.

PMID:
26559663
11.

A new procedure for the cloning, expression and purification of the β-carbonic anhydrase from the pathogenic yeast Malassezia globosa, an anti-dandruff drug target.

Del Prete S, De Luca V, Vullo D, Osman SM, AlOthman Z, Carginale V, Supuran CT, Capasso C.

J Enzyme Inhib Med Chem. 2015 Nov 2:1-6. [Epub ahead of print]

PMID:
26523349
12.

Anion inhibition studies of the dandruff-producing fungus Malassezia globosa β-carbonic anhydrase MgCA.

Del Prete S, Vullo D, Osman SM, AlOthman Z, Capasso C, Supuran CT.

Bioorg Med Chem Lett. 2015 Nov 15;25(22):5194-8. doi: 10.1016/j.bmcl.2015.09.068. Epub 2015 Oct 3.

PMID:
26459213
13.

Changing of bloodstream infections in a medical center neonatal intensive care unit.

Chen IL, Chiu NC, Chi H, Hsu CH, Chang JH, Huang DT, Huang FY.

J Microbiol Immunol Infect. 2015 Sep 10. pii: S1684-1182(15)00846-4. doi: 10.1016/j.jmii.2015.08.023. [Epub ahead of print]

14.

SIXTEEN YEARS OF PITYRIASIS VERSICOLOR IN METROPOLITAN AREA OF PORTO ALEGRE, SOUTHERN BRAZIL.

Heidrich D, Daboit TC, Stopiglia CD, Magagnin CM, Vetoratto G, Amaro TG, Scroferneker ML.

Rev Inst Med Trop Sao Paulo. 2015 Jul-Aug;57(4):277-80. doi: 10.1590/S0036-46652015000400001.

15.

A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor.

Gobbato AA, Babadópulos T, Gobbato CA, Ilha Jde O, Gagliano-Jucá T, De Nucci G.

Expert Opin Investig Drugs. 2015;24(11):1399-407. doi: 10.1517/13543784.2015.1083009. Epub 2015 Sep 30.

PMID:
26419668
16.

Glutathione as a promising anti-hydrophobicity agent against Malassezia spp.

Sivasankar C, Ponmalar A, Bhaskar JP, Pandian SK.

Mycoses. 2015 Oct;58(10):620-31. doi: 10.1111/myc.12370. Epub 2015 Sep 3.

PMID:
26334025
17.

Genotyping and antifungal susceptibility testing of multiple Malassezia pachydermatis isolates from otitis and dermatitis cases in pets: is it really worth the effort?

Álvarez-Pérez S, García ME, Peláez T, Blanco JL.

Med Mycol. 2016 Jan;54(1):72-9. doi: 10.1093/mmy/myv070. Epub 2015 Sep 1.

PMID:
26333353
18.

Differential Expression of Extracellular Lipase and Protease Activities of Mycelial and Yeast Forms in Malassezia furfur.

Juntachai W, Kajiwara S.

Mycopathologia. 2015 Oct;180(3-4):143-51. doi: 10.1007/s11046-015-9900-7. Epub 2015 Jul 15.

PMID:
26173769
19.

Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.

Cafarchia C, Iatta R, Immediato D, Puttilli MR, Otranto D.

Med Mycol. 2015 Sep;53(7):743-8. doi: 10.1093/mmy/myv049. Epub 2015 Jul 10.

PMID:
26162472
20.

Agar Diffusion Procedures for Susceptibility Testing of Malassezia pachydermatis: Evaluation of Mueller-Hinton Agar Plus 2 % Glucose and 0.5 µg/ml Methylene Blue as the Test Medium.

Pasquetti M, Chiavassa E, Tizzani P, Danesi P, Peano A.

Mycopathologia. 2015 Oct;180(3-4):153-8. doi: 10.1007/s11046-015-9913-2. Epub 2015 Jul 3.

PMID:
26138434
Items per page

Supplemental Content

Loading ...
Write to the Help Desk